Cambrian Genomics

Cambrian Genomics

Cambrian Genomics is a biotechnology company developing technologies to synthesize DNA. The company is headquartered in San Francisco, California, and was founded in 2011.

Cambrian Genomics is an American biotechnology company that was founded by Anselm Levskaya, Austen Heinz, George Church, John Mulligan, Lukman Winoto, Reese Jones, and Sagar Indurkhya in 2011, and is headquartered in San Francisco, California. The company uses laser-based 3D printing technologies to make custom DNA strands for its customers.

In 2013, Cambrian Genomics was able to raise $484,013 in crowdfunding for their glowing plant project, which aimed to create a plant that emits light. The project is still ongoing and the company is struggling to produce a plant which makes light unassisted.

Timeline

People

Name
Role
LinkedIn

Aamer Abdullah

Investor

Adam Pisoni

Investor

Adrian Aoun

Investor

Adrian Druzgalski

Investor

Alex Gurevich

Investor

Alex Moskalyuk

Investor

Amer Rehman

Investor

Andrew Rothery

Investor

Andy Dunn

Investor

Andy Pham

Investor

Anselm Levskaya

Founder

Austen Heinz

Founder

Aydin Senkut

Investor

Bre Pettis

Investor

Bryan Johnson

Investor

Cameron Winklevoss

Investor

Carl Bass

Investor

Carol Sands

Investor

Chris Alden

Investor

Craig Largent

Attorney

David Vivero

Investor

David Waxman

Investor

Dominic Rubas

Investor

Dominique Burgauer

Investor

Doug Chertok

Investor

Page 1 of 5

Further reading

Title
Author
Link
Type
Date

A Brief Guide to Genomics

National Human Genome Research Institute

Web

Cambrian Genomics is a Kinko's for DNA laser printing and custom life forms including DNA modified humans

Brian Wang

Web

Cambrian Genomics laser prints DNA to rewrite the physical world

Conner Forrest

Web

FAQ About Genetic and Genomic Science

National Human Genome Research Institute

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.